Vanguard Fiduciary Trust
ZBIO

Vanguard Fiduciary Trust’s Zenas BioPharma ZBIO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46M Buy
254,623
+75,235
+42% +$1.5M ﹤0.01% 2051
2026
Q1 		$3.51M Buy
+179,388
New +$4.03M ﹤0.01% 2266

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's ZBIO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Zenas BioPharma (ZBIO) stake by 42% in Q2 2026, buying an estimated $1.5M and bringing the position to 254,623 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Vanguard Fiduciary Trust first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Vanguard Fiduciary Trust held 254,623 shares of Zenas BioPharma worth $6.46M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 75,235 Zenas BioPharma shares in Q2 2026, an estimated $1.5M.
  • Zenas BioPharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2051 holding.
  • Vanguard Fiduciary Trust first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.